A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography.
about
Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients With Alzheimer's and Parkinson's Disease.Long-Term Intravitreal Ranibizumab as a Potential Additional Risk Factor for Neurodegeneration in Parkinson's Disease: A Case Report.Diagnostic biomarkers for Parkinson's disease at a glance: where are we?
P2860
A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A novel retinal biomarker for ...... optical coherence tomography.
@ast
A novel retinal biomarker for ...... optical coherence tomography.
@en
type
label
A novel retinal biomarker for ...... optical coherence tomography.
@ast
A novel retinal biomarker for ...... optical coherence tomography.
@en
prefLabel
A novel retinal biomarker for ...... optical coherence tomography.
@ast
A novel retinal biomarker for ...... optical coherence tomography.
@en
P2093
P2860
P356
P1433
P1476
A novel retinal biomarker for ...... optical coherence tomography.
@en
P2093
Ivan Bodis-Wollner
Jerome Sherman
Mary Durbin
Samantha Slotnick
Shahnaz Miri
Sofya Glazman
P2860
P304
P356
10.1002/MDS.26411
P407
P577
2015-09-04T00:00:00Z